World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...

Pfizer Inc. has secured an exclusive global licensing agreement with 3SBio, Inc., a leading Chinese biopharma, for SSGJ-707.

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

The Conversation asked Nicole Hassoun, a professor at Binghamton University and executive director of Global Health Impact, ...

Global health leaders called for the Pandemic Agreement adopted at the 78th World Health Assembly to deliver where past efforts failed—equitable access to life-saving technologies and services during ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

In a statement issued to Campaign Asia-Pacific, WPP has confirmed the win: "We are pleased to confirm that The Coca-Cola Company has renewed its partnership with WPP Open X, and we look forward to ...

Dixon Technologies' outperform rating is sustained by BNP Paribas India, citing remarkable FY25 results and future ...

No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 ...

The largest Chinese licensing deal behind Pfizer’s is Novartis’ partnership with Shanghai Argo Biopharma, worth potentially ...

While President Donald Trump may wish he lives and works in the Hogwarts School of Witchcraft and Wizardry and has Harry ...